RIPK2 was found to be significantly upregulated in rectal tumor tissues compared with normal adjacent mucosa, suggesting that RIPK2 plays a vital role in the progression of IBD to CRC (Flebbe et al., 2019). This evidence concerns the gene RIPK2 and rectal neoplasm.